GT Biopharma Inc.

2.25
-0.06 (-2.60%)
At close: Apr 11, 2025, 3:13 PM
2.30
2.16%
After-hours: Apr 11, 2025, 05:33 PM EDT

GT Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a 4K 7K 2K 1K
n/a n/a n/a n/a n/a -4K -7K -2K -1K
-14.36M -13.58M -21.26M -57.52M -6.76M -16.06M -250.07M -135.57M -9.37M
402K 567K 292K 38K 3.32K 2.13K n/a n/a n/a
-13.16M -7.6M -20.88M -58.01M -28.3M -38.65M -259.19M -143.25M 21.03M
-13.16M -7.6M -20.5M -58.69M -31.62M -40.77M -259.19M -143.25M 21.03M
8.57M 7.11M 12.45M 47.92M 6.28M 9.79M 12.49M 134.5M 8.4M
5.8M 6.47M 8.81M 9.59M 485K 1.67M 9.07M 1.07M 975K
n/a n/a n/a -242.76K -12.6M n/a n/a n/a n/a
14.36M 13.58M 21.26M 57.52M 6.76M 11.46M 21.55M 135.57M 9.37M
n/a n/a 8K 718K 3.32M 2.13M 9.12M 8.6M 6.55M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 13.58M 21.26M 57.52M 6.76M 11.46M 21.55M 135.57M 9.37M
n/a n/a -381K 680K 3.32M 2.13M -228.51M 7.68M -30.41M
1.9M 1.35M 1.06M 8.65M 10.38M 3.74M 2.96M 986.42K 4.79K
1.9M 1.35M 1.06M 8.65M 10.38M 3.79M 2.96M 986.42K 4.79K
-6.94 -5.64 -19.3 -6.78 -3.05 -10.91 -87.7 -145.22 4.39K
-6.94 -5.64 -19.3 -6.78 -3.05 -10.76 -87.7 -145.22 4.39K
-14.36M 5.98M -20.96M -57.48M -24.98M -11.45M -250.06M -135.57M -9.37M
n/a -7.6M -20.88M -57.54M -24.98M -36.52M -250.07M -135.57M -9.37M
n/a 13.58M 21.26M 57.52M 4K 4K 7K 2K 1K